{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:28:22Z","timestamp":1761863302341},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.cjca.2014.04.034","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T14:58:28Z","timestamp":1399388308000},"page":"1170-1176","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association Between Drug-Eluting Stent Type and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"30","author":[{"given":"William","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Kotowycz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Sibbald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"McGeoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Hatton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Ing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Osten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H.","family":"Seidelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Barolet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"D\u017eav\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.04.034_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCINTERVENTIONS.108.828954","article-title":"The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era","volume":"2","author":"Appleby","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.04.034_bib2","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.jacc.2011.06.056","article-title":"Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked cathpci registry-cms claims database","volume":"58","author":"Tsai","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcin.2008.06.012","article-title":"In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry","volume":"2","author":"Latif","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.04.034_bib4","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2014.04.034_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease","volume":"296","author":"Coca","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.04.034_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ccd.23199","article-title":"Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years","volume":"80","author":"Simsek","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.04.034_bib7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.amjcard.2005.10.018","article-title":"Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents","volume":"97","author":"Kuchulakanti","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib8","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1253\/circj.71.1525","article-title":"Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients","volume":"71","author":"Ishio","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.cjca.2014.04.034_bib9","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.amjcard.2010.07.011","article-title":"Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials)","volume":"106","author":"Garg","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacc.2010.09.032","article-title":"Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired p2y12 inhibition by clopidogrel","volume":"57","author":"Morel","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib11","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.04.034_bib12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib13","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/j.1523-1755.2004.09203.x","article-title":"Cardiovascular risk in chronic kidney disease","author":"Anavekar","year":"2004","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.cjca.2014.04.034_bib14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.amjcard.2007.11.009","article-title":"Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention","volume":"101","author":"Osten","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib15","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcin.2011.05.022","article-title":"Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention","volume":"4","author":"Hanna","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.04.034_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.108.803528","volume":"119","author":"Stone","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.04.034_bib17","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.04.034_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacc.2011.02.023","volume":"58","author":"Smits","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib19","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1161\/CIRCULATIONAHA.106.173220","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.04.034_bib20","series-title":"Analysis of health care data using SAS","article-title":"Chapter 3. Propensity score matching for estimating treatment effect","author":"Austin","year":"2010"},{"key":"10.1016\/j.cjca.2014.04.034_bib21","unstructured":"Parsons LS. Reducing bias in propensity score matched-pair sample using greedy matching techniques. Paper presented at: Proceedings of the twenty-sixth Annual SAS Users Group International Conference. Long Beach, CA: SAS Institute Inc,\u00a02001."},{"key":"10.1016\/j.cjca.2014.04.034_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.CIR.0000109138.84579.FA","article-title":"Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the \u201creal world\u201d: The rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (Research) Registry","volume":"109","author":"Lemos","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.04.034_bib23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of \u201cnew-generation\u201d drug-eluting stents: a report from The Nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"33","author":"Sarno","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.04.034_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCINTERVENTIONS.111.963256","article-title":"Everolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials","volume":"4","author":"de Waha","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.04.034_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCINTERVENTIONS.111.966549","article-title":"Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study","volume":"5","author":"Park","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.04.034_bib26","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(12)61336-1","article-title":"Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial","volume":"380","author":"Camenzind","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.04.034_bib27","doi-asserted-by":"crossref","first-page":"E1894","DOI":"10.1016\/S0735-1097(11)61894-9","article-title":"Comparison of 4 years clinical outcome of stent implantation in renal failure patients with dialysis: comparison with bare metal stents, first generation drug-eluting stents and second generation drug-eluting stents","volume":"57","author":"Nakamura","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib28","first-page":"103","article-title":"The impact of new generation drug-eluting stent implantation on patients with chronic kidney disease and a single lesion in the proximal segment of the left anterior descending artery","volume":"52","author":"Toutouzas","year":"2011","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ahj.2012.02.006","article-title":"The SPIRIT V diabetic study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Libert\u00e9 paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions","volume":"163","author":"Grube","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2014.04.034_bib30","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.jacc.2010.10.006","article-title":"Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system)","volume":"56","author":"Kereiakes","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.04.034_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.04.034_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ahj.2009.04.013","article-title":"Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation","volume":"158","author":"Ota","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2014.04.034_bib33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehq480","article-title":"Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry","volume":"32","author":"Otsuka","year":"2011","journal-title":"Eur Heart J"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14003201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14003201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T05:51:33Z","timestamp":1538632293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14003201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0828282X14003201"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.04.034","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Drug-Eluting Stent Type and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}